Replies to post #119859 on Anavex Life Sciences Corp (AVXL)

[Batermere]

I think we'd all rather have some substantial news from Missling rather than seeing him purchase another measly 375 shares/week. That does absolutely nothing for shareholder value. The longer we go with no news the longer the BEATDOWN will continue. Clinical Stage Biotechs SPs are news driven. That is a fact.